Pfizer Limited · NSE:PFIZER

Pfizer Limited financial statements

Pfizer Limited's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in INR

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue25.2B22.8B21.9B24.2B26.1B22.4B21.5B20.8B19.7B19.7B
Cost of revenue13.1B8.16B7.98B8.78B9.53B8.03B7.98B7.53B7.46B8.05B
Gross profit12.1B14.7B13.9B15.5B16.6B14.4B13.5B13.3B12.2B11.6B
Research and development275.0M
Selling, general and administrative1.98B3.72B3.48B3.32B4.04B3.62B3.68B3.60B3.50B3.38B
Operating income8.46B10.4B9.61B11.5B11.8B10.1B9.00B8.87B8.01B7.53B
Depreciation and amortization577.3M607.9M622.8M1.06B1.15B1.09B1.03B713.9M662.5M629.3M
EBITDA9.04B11.0B10.2B12.6B12.9B11.2B10.0B9.58B8.68B8.16B
Interest expense94.8M85.0M154.3M133.9M107.0M153.9M108.5M12.9M4.20M19.6M
Income before tax9.76B10.2B7.46B8.24B7.73B6.69B6.42B6.60B5.48B5.17B
Income tax2.53B2.48B1.95B2.00B1.60B1.71B1.33B2.31B1.88B1.80B
Net income7.22B7.68B5.51B6.24B6.13B4.98B5.09B4.29B3.60B3.37B
Earnings per share, basic157.92167.79120.51136.38133.89108.77111.2993.7878.7073.61

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents1.03B5.13B1.12B366.0M627.6M1.57B17.6B738.1M507.3M675.9M
Short-term investments29.9B22.9B19.1B18.0B15.5B9.41B4.31B18.2B17.0B14.3B
Receivables1.82B1.93B1.88B2.39B1.92B2.40B3.08B3.31B3.49B2.97B
Inventory4.73B4.76B4.34B4.34B4.18B4.49B4.35B3.87B2.97B3.22B
Current assets38.0B35.1B27.7B25.3B24.0B19.1B30.5B27.2B24.2B20.5B
Property, plant and equipment1.79B1.51B1.85B2.20B1.95B2.15B714.3M825.4M871.9M
Goodwill5.27B5.27B5.27B5.27B5.27B5.27B5.27B5.27B5.27B5.27B
Total assets49.2B49.1B42.3B40.0B39.0B32.7B44.1B39.4B36.9B32.7B
Accounts payable2.16B1.52B1.66B2.17B2.64B2.84B4.27B4.36B4.96B32.3M
Current liabilities6.27B5.70B5.47B6.57B8.53B7.74B8.73B8.92B9.54B7.80B
Long-term debt25.0M
Total debt702.3M1.08B945.4M1.34B1.67B1.06B1.28B25.0M25.0M25.0M
Total liabilities7.19B6.94B6.33B7.93B10.4B8.73B10.1B9.29B10.1B8.52B
Shareholders' equity42.0B42.2B36.0B32.1B28.6B23.9B34.0B30.1B26.8B24.2B
Shares outstanding45.7M45.7M45.7M45.7M45.8M45.8M45.8M45.8M45.8M45.8M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations11.4B6.60B2.57B3.56B6.67B4.27B3.23B978.1M3.32B3.29B
Capital spending-252.3M-281.5M-189.3M-649.8M-153.1M-177.0M-168.9M-44.9M-1.03B-252.9M
Free cash flow11.2B6.32B2.38B2.91B6.52B4.10B3.06B933.2M2.29B3.04B
Cash from investing-7.39B-713.4M-713.4M-360.5M-5.75B-4.69B15.3B351.2M-2.38B-2.50B
Cash from financing-7.97B-2.05B-2.05B-3.46B-1.81B-15.7B-1.64B-1.10B-1.10B-825.9M
Dividends paid-7.52B-1.60B-1.83B-2.97B-1.60B-15.2B-1.03B-910.5M-917.3M-686.2M
Change in cash26.0B3.83B754.0M-261.6M-884.5M-16.1B16.9B230.8M-168.6M-34.7M